A Journey of Pain, Purpose, and Perseverance: A special seminar in memory of Shakir Cannon, sickle cell patient advocate and leading voice in discussions on CRISPR Genome Editing, Precision Medicine, and Social Justice.

Seminar | February 27 | 4-5 p.m. | 115 Energy Biosciences Building

 Michael Friend, Co-founder, Minority Coalition for Precision Medicine, Health Ministries Network

 Innovative Genomics Institute

Despite being the first “molecular disease” ever discovered, and despite being the most common genetic disease in the US, sickle cell disease (SCD), a disease that predominantly affects people from African descent, is still a truly devastating disease with no universal cure. Long under- and unequally-served by the medical and research communities, SCD is getting renewed attention as CRISPR researchers set their sights on finally curing this disease with gene editing.

In this special seminar, Michael Friend discusses this forgotten disease, his relationship with SCD advocate, Shakir Cannon, and how the scientific and minority communities can move forward. The work of Michael and Shakir has helped bridge minority communities with medical researchers to create a dialog surrounding the promise of precision medicine and gene editing.

 Faculty, Staff, Students - Graduate

 All Audiences

 Appetizers and drinks

 lwitkowsky@berkeley.edu

 Coming Soon, available February 27, 2018: Michael Friend: A Journey of Pain, Purpose, and Perseverance in YouTube stream